NorthCrest Asset Manangement’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
Other funds holding VIR
SIAU
O
NorthCrest Asset Manangement's VIR Position: Q4 2024 in Review
NorthCrest Asset Manangement sold out of Vir Biotechnology (VIR) in Q4 2024, closing a stake of 11,700 shares — an estimated $87.6K sold.
NorthCrest Asset Manangement first reported a position in VIR in Q4 2021 and held it in 12 quarters. The position peaked at $435K in Q4 2021. 208 funds tracked by Wall St. Rank hold VIR as of Q4 2024.
- NorthCrest Asset Manangement reported no remaining Vir Biotechnology position as of Q4 2024 after selling out during the quarter.
- NorthCrest Asset Manangement sold 11,700 Vir Biotechnology shares in Q4 2024, an estimated $87.6K.
- NorthCrest Asset Manangement first reported a position in Vir Biotechnology in Q4 2021 and held it in 12 quarters.
- NorthCrest Asset Manangement's Vir Biotechnology position peaked at $435K in Q4 2021.
- 208 funds tracked by Wall St. Rank held Vir Biotechnology as of Q4 2024.
Based on NorthCrest Asset Manangement's 13F filing for Q4 2024, filed 10 Jan 2025.